Gamification for patient care – medical education, and virtual engagement

Gamification for patient care uses extrinsic and intrinsic rewards to motivate users to change their behaviours. It may be helpful (together with other tools) for preventive medicine by encouraging things like smoking cessation, healthy sleep habits, good nutrition, weight management, and health literacy.   Employers have the opportunity to take this type of gamification to […]

Quality Manual – what is it and what should it contain?

Quality Manual, continuous improvement, and overall customer satisfaction, you need a quality management system (QMS). An effective pharmaceutical quality management system promotes a customer-focused culture, encourages employee involvement, and incorporates other QMS principles for highly regulated industries. Here are eight things you should include when building your quality management system.   Organizations succeed when they […]

Life Science Marketing Challenges of mergers and acquisitions – Understanding the impact

Mergers and acquisitions are with few exceptions organizationally complex and emotionally demanding. Not only is there uncertainty among employees about the future but the passion and purpose of the work is an intrinsic motivator that most often stops with limited warning. “It can be like having trained for a marathon and arriving at the race […]

Rebranding of sanofi for pharmaceuticals – All tightened up for rolling out a new logo and purpose

Rebranding of sanofi which include some of the sub brands like Sanofi Pasteur and Sanofi Genzyme will be united under the Sanofi brand. Internally staffers will continue to work under one of four global business units: Pasteur is the vaccines business unit and Genzyme is the specialty care business unit. The other two units are […]

Pharma 4.0 Technologies – Effective implementation strategy

The International Society for Pharmaceutical Engineering’s (ISPE) Pharma 4.0 Special Interest Group (SIG) has been working since 2015 to translate how Industry 4.0 impacts pharmaceutical regulations and pharma manufacturing’s unique requirements. ISPE elieves moving to Pharma 4.0 Technologies represents a competitive advantage to the extent that not embracing its potential might be a business  risk.  […]

Freebies to doctors – Preventing tax cut claims by pharmaceuticals companies

The 2022 budget prohibits pharmaceutical companies from claiming freebies to doctors tax cuts under section 37 of the act. This simply means that these expenses are not considered business deductions and  will count as taxable profit for the pharmaceutical industry.    The Memorandum of Understanding explaining the provisions of the Expropriation Bill 2022 states that […]

Indian Union Budget 2022 for the Pharmaceutical sector

The Healthcare and Pharmaceutical Sector responded positively to the Union Budget 2022 presented by Finance Minister Nirmala Sitharaman. While the Union Budget 2022 acknowledged the accelerated improvement in health infrastructure in the past two years, it concentrated on the development of a ‘National Tele Mental Health Programme’ to further strengthen mental health services. In the […]

Return on investment – Defining sales and marketing

Today’s data-driven digital marketing  relies on  more than a single irrelevant metric, such as click-through rate, cost-per-acquisition (CPA), and cost-effectiveness (ROAS). To justify an investment, marketers need to show management and executive-level decision makers how these indicators affect their bottom line. Measuring Return on investment  is more important than ever for content marketers. But are […]

Data transparency will built the future of trust

Data transparency, Business have a customer “trust” issue. What’s more, the issue is deteriorating. Consistently, the news features are loaded up with associations selling, manhandling, and misusing customer information. Furthermore with ill defined situations that accompany advanced information driven abilities like computerized reasoning (AI) and AI (ML), we are going towards a few intriguing times. […]